Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 5 of 5

Full-Text Articles in Other Pharmacy and Pharmaceutical Sciences

Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers Jan 2021

Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers

Pharmacy Posters

  • The use of spot urine sodium (UNa)>60 mmol/L as an objective measure to guide diuretic therapy in patients receiving bolus intravenous loop diuretics has been associated with increased weight loss and decreased length of stay.
  • There is limited published data evaluating UNa use in patients receiving continuous intravenous loop diuretic infusions.


Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras Jan 2020

Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras

Pharmacy Posters

Introduction

  • Heparin-induced thrombocytopenia (HIT) is a rare adverse reaction
  • Calculating a 4T score prior to ordering a heparin-PF4 immunoassay is recommended. For a score < 4, HIT probability is low and an assay is not advised
  • If high suspicion of HIT (4T greater than or equal to 4), an assay should be ordered, all heparin products discontinued, and a non-heparin anticoagulant initiated.

Purpose

  • Determine if heparin immunoassay ordering was indicted according to retrospective 4T score
  • Assess anticoagulation prescribing depending on the result of the assay
  • Serve as a pre-group for a planned perverse post-HIT order set implementation analysis


Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman Jan 2019

Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman

Pharmacy Posters

Introduction

  • Infusion-related reactions (IRRs) are well-known adverse drug reactions of many biological agents and antineoplastic medications
  • While typically mild-to-moderate in intensity, IRRs can be severe, with potentially life-threatening consequences requiring urgent interventions
  • Appropriate use of pre-treatment medications, such as corticosteroids, antihistamines, intravenous fluids, and antiemetics reduces the incidence and severity of IRRs

Purpose

  • Evaluate the use of pre-treatment medications in patients with experienced IRRs at an outpatient infusion center
  • Identify opportunities to improve treatment plans and reduce the occurrence of IRRs


Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras Jan 2019

Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras

Pharmacy Posters

Introduction

  • Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
  • ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019

Purpose

  • To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications


Integration Of A Pharmacist In A Pediatric Medical Home For Children With Medical Complexity, Alannah K. Yoder, Richard K. Ogden Jr., Ingrid A. Larson, Emily J. Goodwin Oct 2018

Integration Of A Pharmacist In A Pediatric Medical Home For Children With Medical Complexity, Alannah K. Yoder, Richard K. Ogden Jr., Ingrid A. Larson, Emily J. Goodwin

Pharmacy Posters

Background/Objectives

Children with medical complexity require unique care, specialized attention, and a dedicated team to meet the needs of the patient & caregivers. Drug-therapy related problems in complex, chronic conditions influence financial, institutional, and patient outcomes. The addition of a pharmacist allows for collaboration and delivery of comprehensive medication management in order to provide value-added medication services to optimize complex therapeutic regimens and patient outcomes through evidence-based practice, medication adherence, medication use coordination, and medication safety processes.

Description

Our program provides a pediatric medical home for hundreds of children with medical complexity. Families are cared for by a comprehensive …